These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29055972)

  • 21. Management of patients with diabetes and heart failure with reduced ejection fraction: An international comparison.
    Arnold SV; Yap J; Lam CSP; Tang F; Tay WT; Teng THK; McGuire DK; Januzzi JL; Fonarow GC; Masoudi FA; Kosiborod M
    Diabetes Obes Metab; 2019 Feb; 21(2):261-266. PubMed ID: 30136348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry.
    Sato Y; Yoshihisa A; Oikawa M; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
    J Cardiol; 2019 Jun; 73(6):459-465. PubMed ID: 30718015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort study.
    Sessa M; Mascolo A; Mortensen RN; Andersen MP; Rosano GMC; Capuano A; Rossi F; Gislason G; Enghusen-Poulsen H; Torp-Pedersen C
    Eur J Heart Fail; 2018 Mar; 20(3):548-556. PubMed ID: 29159953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease.
    Canepa M; Franssen FME; Olschewski H; Lainscak M; Böhm M; Tavazzi L; Rosenkranz S
    JACC Heart Fail; 2019 Oct; 7(10):823-833. PubMed ID: 31521680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION).
    Mentz RJ; Schulte PJ; Fleg JL; Fiuzat M; Kraus WE; Piña IL; Keteyian SJ; Kitzman DW; Whellan DJ; Ellis SJ; O'Connor CM
    Am Heart J; 2013 Feb; 165(2):193-9. PubMed ID: 23351822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure.
    Lainscak M; Hodoscek LM; Düngen HD; Rauchhaus M; Doehner W; Anker SD; von Haehling S
    Wien Klin Wochenschr; 2009; 121(9-10):309-13. PubMed ID: 19562292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
    Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM
    Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction.
    Butler J; Yang M; Manzi MA; Hess GP; Patel MJ; Rhodes T; Givertz MM
    J Am Coll Cardiol; 2019 Mar; 73(8):935-944. PubMed ID: 30819362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of chronic obstructive pulmonary disease on long-term hospitalization and mortality in patients with heart failure with reduced ejection fraction.
    Lin CH; Yeh JK; Lin TY; Lo YL; Chang BJ; Ju JS; Chiu TH; Tung PH; Huang YJ; Lin SM
    BMC Pulm Med; 2023 Feb; 23(1):67. PubMed ID: 36805703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence, clinical correlates, and outcomes of anaemia in multi-ethnic Asian patients with heart failure with reduced ejection fraction.
    Goh VJ; Tromp J; Teng TK; Tay WT; Van Der Meer P; Ling LH; Siswanto BB; Hung CL; Shimizu W; Zhang S; Narasimhan C; Yu CM; Park SW; Ngarmukos T; Liew HB; Reyes E; Yap J; MacDonald M; Richards MA; Anand I; Lam CSP;
    ESC Heart Fail; 2018 Aug; 5(4):570-578. PubMed ID: 29604185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chronic obstructive pulmonary disease on inpatients with heart failure. GESAIC study results].
    Recio-Iglesias J; Grau-Amorós J; Formiga F; Camafort-Babkowski M; Trullàs-Vila JC; Rodríguez A;
    Med Clin (Barc); 2010 Apr; 134(10):427-32. PubMed ID: 20149399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure.
    Rusinaru D; Saaidi I; Godard S; Mahjoub H; Battle C; Tribouilloy C
    Am J Cardiol; 2008 Feb; 101(3):353-8. PubMed ID: 18237599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland.
    Hawkins NM; Jhund PS; Simpson CR; Petrie MC; Macdonald MR; Dunn FG; Macintyre K; McMurray JJ
    Eur J Heart Fail; 2010 Jan; 12(1):17-24. PubMed ID: 19951962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
    Le Jemtel TH; Padeletti M; Jelic S
    J Am Coll Cardiol; 2007 Jan; 49(2):171-80. PubMed ID: 17222727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
    Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
    Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
    Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database.
    Paolillo S; Mapelli M; Bonomi A; Corrà U; Piepoli M; Veglia F; Salvioni E; Gentile P; Lagioia R; Metra M; Limongelli G; Sinagra G; Cattadori G; Scardovi AB; Carubelli V; Scrutino D; Badagliacca R; Raimondo R; Emdin M; Magrì D; Correale M; Parati G; Caravita S; Spadafora E; Re F; Cicoira M; Frigerio M; Bussotti M; Minà C; Oliva F; Battaia E; Belardinelli R; Mezzani A; Pastormerlo L; Di Lenarda A; Passino C; Sciomer S; Iorio A; Zambon E; Guazzi M; Pacileo G; Ricci R; Contini M; Apostolo A; Palermo P; Clemenza F; Marchese G; Binno S; Lombardi C; Passantino A; Perrone Filardi P; Agostoni P
    Eur J Heart Fail; 2017 Jul; 19(7):904-914. PubMed ID: 28233458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.
    Tromp J; Tay WT; Ouwerkerk W; Teng TK; Yap J; MacDonald MR; Leineweber K; McMurray JJV; Zile MR; Anand IS; Richards AMR; Lam CSP;
    PLoS Med; 2018 Mar; 15(3):e1002541. PubMed ID: 29584721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.